Cytosar Solution 100 mg/5 ml, Injektionslöung

7680548450142 CH-54845 Lösung
Cytosar Solution 100 mg/5 ml, Injektionslöung
Cytosar Solution 100 mg/5 ml, Injektionslöung
Cytosar Solution 100 mg/5 ml, Injektionslöung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
15/05/2023
Summary of Product Characteristics
Français
15/05/2023
Summary of Product Characteristics
Italien
15/05/2023

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
13.39 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 13.10
Specialties list
Yes
Generic
No
SL addition date: 01/10/2015

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
54845
Drug name
Cytosar Solution, Injektionslösung
Galenic form
LSINJ
ATC Code
L01BC01
Authorization status
Z
Dispensing category
A
First authorization
15/12/1999
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Zytostatikum

Package details

Description (FR)
CYTOSAR Solution sol inj 100 mg/5ml Onco-Tain 5 ml
Description (DE)
CYTOSAR Solution Inj Lös 100 mg/5ml Onco-Tain 5 ml
Market launch
15/12/1999
Narcotic (BTM)
No

Other package sizes (3)

CYTOSAR Solution sol inj 0.5 g/25ml Cytosafe 25 ml
1 DUR
GTIN: 7680548450227
Not in V1
None
1 DUR
GTIN: None
Not in V1
CYTOSAR Solution sol inj 2 g/20ml Onco-Tain 20 ml
1 DUR
GTIN: 7680548450494
View